Vimarsana
Biggest News Aggregation in the World

Lead Karyopharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lead Karyopharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lead Karyopharm Today - Breaking & Trending Today

Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer - Vimarsana News

Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer

Published: March 30, 2022

Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
United KingdomRichard PaulsonReshma RangwalaMichael KauffmanSharon ShachamSelective Inhibitor Of Nuclear ExportKauffmanwill Transition Out Of The Company OnKaryopharm Therapeutics IncDrug AdministrationMerck CoUniversity Of Cincinnati College MedicineCompany Scientific Advisory BoardPrnewswire Karyopharm Therapeutics IncExchange CommissionHospital Of The University PennsylvaniaTransition Of CoKaryopharm Clinical Development ProgramsDuke UniversityLead KaryopharmClinical Development ProgramsKauffmanwill Transition OutShacham Will ContinueScientific Advisory BoardAdvisory CapacityChief Medical
Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer - Vimarsana News

Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer

Published: March 29, 2022

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...

Source: prnewswire.com
Related Topics:
United KingdomRichard PaulsonReshma RangwalaMichael KauffmanSharon ShachamSelective Inhibitor Of Nuclear ExportKauffmanwill Transition Out Of The Company OnKaryopharm Therapeutics IncMerck CoUniversity Of Cincinnati College MedicineCompany Scientific Advisory BoardPrnewswire Karyopharm Therapeutics IncTransition Of CoHospital Of The University PennsylvaniaKaryopharm Clinical Development ProgramsDuke UniversityLead KaryopharmClinical Development ProgramsKauffmanwill Transition OutShacham Will ContinueScientific Advisory BoardAdvisory CapacityChief MedicalChief Executive OfficerChief Medical Officer